Table 6. Use of miltefosine for Balamuthia GAE.
AmB: amphotericin B, Rif: rifampin, Flu: fluconazole, AZM: azithromycin, Dex: dexamethasone, Acy: acyclovir, Van: vancomycin, CFX: ceftriaxone, Deoxy AmB IV: deoxycholate amphotericin B intravenously, TMP-SMX: trimethoprim-sulfamethoxazole, 5-FC: flucytosine, GAE: granulomatous amebic encephalitis
| Reference | Case (age, sex) | Diagnosis from symptom to onset | Initial treatment | Miltefosine initiation from diagnosis | Total days of treatment | Outcome | Follow-up |
| [33] | 21, female | Four months | Fluconazole, clotrimazole, topical steroid, fluconazole and clarithromycin, TMP-SMX, albendazole | > two years | one year | Survived | 30 months of treatment including 12 months without therapy or recurrence |
| [34] | 26, male | Two months | Dex, albendazole, Azm, Flu,TMP-SMX | Third week | 114 days | Survived | Continued nine months of treatment minus miltefosine |
| [35] | 69, female | Three days | Azm, Flu, 5-FC, Sulfadiazine, pentamidine | On 3rd day | Three days | Died | A few weeks after transfer to hospice care |
| [36] | 11, male | Weeks | Dex, AmB, Flu, Azithromycin, 5-FC, Sulfadiazine, pentamidine, metronidazole | On 7th day | 27 days | Died | Palliative care on day 49 |